Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Acquisitions (2018 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Acquisitions for 3 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Acquisitions changed N/A to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at $2.5 million for FY2025, N/A changed from the prior year.
  • Acquisitions hit $1.0 million in Q4 2025 for Cumberland Pharmaceuticals, up from $611600.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $13.5 million in Q1 2022 to a low of -$326262.0 in Q2 2025.